Digoxin Immune Fab therapy in the management of digitalis intoxication: Safety and efficacy results of an observational surveillance study
Authors:
- Thomas L. WengerTWThomas L. Wenger
- Vincent P. CarpenterVCVincent P. Carpenter
- Hugh H. TilsonHTHugh H. Tilson
- Mark A. HlatkyMHMark A. Hlatky
- Curt D. FurbergCFCurt D. Furberg
- Charles H. KirkpatrickCKCharles H. Kirkpatrick
- Harold C. StraussHSHarold C. Strauss
- Thomas W. SmithTSThomas W. Smith
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunotherapy in the Poisoned PatientMedical Toxicology, 1986
- Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments.Circulation, 1978
- Reversal of Advanced Digoxin Intoxication with Fab Fragments of Digoxin-Specific AntibodiesNew England Journal of Medicine, 1976
- Biologic Activity of Digoxin-Specific AntiseraJournal of Clinical Investigation, 1972
- The Isolation of Digoxin-Specific Antibody and Its Use in Reversing the Effects of DigoxinProceedings of the National Academy of Sciences, 1971
- Reversal of Digoxin Toxicity with Specific AntibodiesJournal of Clinical Investigation, 1971
- Suicidal and Accidental Digoxin IngestionCirculation, 1971
- Immunological protection against digoxin toxicityJournal of Clinical Investigation, 1971
- Determination of Therapeutic and Toxic Serum Digoxin Concentrations by RadioimmunoassayNew England Journal of Medicine, 1969
- Digoxin-specific antibodies.Proceedings of the National Academy of Sciences, 1967